NASDAQ:PETS - 1-800-PetMeds Stock Price, Price Target & More

$35.70 -0.35 (-0.97 %)
(As of 04/22/2018 10:20 AM ET)
Previous Close$35.70
Today's Range$35.36 - $36.37
52-Week Range$22.58 - $57.80
Volume724,698 shs
Average Volume490,573 shs
Market Capitalization$735.46 million
P/E Ratio30.51
Dividend Yield2.80%
Beta0.98

About 1-800-PetMeds (NASDAQ:PETS)

1-800-PetMeds logoPetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. It markets its products through Internet; telephone contact center; and direct mail/print through 1-800-PetMeds catalogs, brochures, and postcards under various brands. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.24%
Quick Ratio3.36%

Price-To-Earnings

Trailing P/E Ratio30.51
Forward P/E Ratio20.17
P/E Growth1.66

Sales & Book Value

Annual Sales$249.18 million
Price / Sales2.95
Cash Flow$1.2268 per share
Price / Cash29.10
Book Value$4.55 per share
Price / Book7.85

Profitability

EPS (Most Recent Fiscal Year)$1.17
Net Income$23.81 million
Net Margins12.84%
Return on Equity34.04%
Return on Assets27.74%

Miscellaneous

Employees187
Outstanding Shares20,600,000

How to Become a New Pot Stock Millionaire

1-800-PetMeds (NASDAQ:PETS) Frequently Asked Questions

What is 1-800-PetMeds' stock symbol?

1-800-PetMeds trades on the NASDAQ under the ticker symbol "PETS."

How often does 1-800-PetMeds pay dividends? What is the dividend yield for 1-800-PetMeds?

1-800-PetMeds declared a quarterly dividend on Monday, January 22nd. Shareholders of record on Monday, February 5th will be given a dividend of $0.25 per share on Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date is Friday, February 2nd. This is an increase from 1-800-PetMeds's previous quarterly dividend of $0.20. View 1-800-PetMeds' Dividend History.

How were 1-800-PetMeds' earnings last quarter?

1-800-PetMeds (NASDAQ:PETS) issued its quarterly earnings data on Monday, January, 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business earned $60.10 million during the quarter, compared to the consensus estimate of $56.76 million. 1-800-PetMeds had a net margin of 12.84% and a return on equity of 34.04%. 1-800-PetMeds's revenue for the quarter was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.24 EPS. View 1-800-PetMeds' Earnings History.

When is 1-800-PetMeds' next earnings date?

1-800-PetMeds is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for 1-800-PetMeds.

What price target have analysts set for PETS?

5 Wall Street analysts have issued 1 year price objectives for 1-800-PetMeds' shares. Their forecasts range from $19.00 to $58.00. On average, they expect 1-800-PetMeds' share price to reach $41.00 in the next twelve months. View Analyst Ratings for 1-800-PetMeds.

Who are some of 1-800-PetMeds' key competitors?

Who are 1-800-PetMeds' key executives?

1-800-PetMeds' management team includes the folowing people:
  • Mr. Menderes Akdag, Chief Exec. Officer, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO, Principal Accounting Officer & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Has 1-800-PetMeds been receiving favorable news coverage?

Press coverage about PETS stock has trended somewhat positive recently, according to Accern. The research firm identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. 1-800-PetMeds earned a news impact score of 0.20 on Accern's scale. They also assigned media headlines about the company an impact score of 45.38 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of 1-800-PetMeds?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 1-800-PetMeds' stock price today?

One share of PETS stock can currently be purchased for approximately $35.70.

How big of a company is 1-800-PetMeds?

1-800-PetMeds has a market capitalization of $735.46 million and generates $249.18 million in revenue each year. The company earns $23.81 million in net income (profit) each year or $1.17 on an earnings per share basis. 1-800-PetMeds employs 187 workers across the globe.

How can I contact 1-800-PetMeds?

1-800-PetMeds' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for 1-800-PetMeds (PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  207 (Vote Underperform)
Total Votes:  299
MarketBeat's community ratings are surveys of what our community members think about 1-800-PetMeds and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

1-800-PetMeds (NASDAQ:PETS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for 1-800-PetMeds in the last 12 months. Their average twelve-month price target is $41.00, suggesting that the stock has a possible upside of 14.85%. The high price target for PETS is $58.00 and the low price target for PETS is $19.00. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.202.202.202.20
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $41.00$41.00$41.00$40.00
Price Target Upside: 14.85% upside12.77% downside12.77% downside20.66% upside

1-800-PetMeds (NASDAQ:PETS) Consensus Price Target History

Price Target History for 1-800-PetMeds (NASDAQ:PETS)

1-800-PetMeds (NASDAQ:PETS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Northcoast ResearchSet Price TargetBuy$58.00HighView Rating Details
10/27/2017Noble FinancialReiterated RatingHoldN/AView Rating Details
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00LowView Rating Details
8/24/2017SidotiUpgradeNeutral -> Buy$47.00HighView Rating Details
8/21/2017Craig HallumReiterated RatingHold$43.00 -> $40.00HighView Rating Details
(Data available from 4/22/2016 forward)

Earnings

1-800-PetMeds (NASDAQ:PETS) Earnings History and Estimates Chart

Earnings by Quarter for 1-800-PetMeds (NASDAQ:PETS)

1-800-PetMeds (NASDAQ:PETS) Earnings Estimates

2018 EPS Consensus Estimate: $1.51
2019 EPS Consensus Estimate: $1.94
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.40$0.40$0.40
Q2 20182$0.28$0.28$0.28
Q3 20182$0.33$0.45$0.39
Q4 20182$0.43$0.44$0.44
Q1 20192$0.51$0.58$0.55
Q2 20192$0.42$0.50$0.46
Q3 20192$0.35$0.49$0.42
Q4 20192$0.45$0.57$0.51

1-800-PetMeds (NASDAQ PETS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018$0.47N/AView Earnings Details
1/22/2018Q3 2018$0.33$0.44$56.76 million$60.10 millionViewListenView Earnings Details
10/23/2017Q2 2018$0.30$0.43$63.41 million$66.70 millionViewN/AView Earnings Details
7/24/2017Q1 2018$0.38$0.45$77.32 million$79.66 millionViewN/AView Earnings Details
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
10/18/2010Q2 2011$0.26$0.22ViewN/AView Earnings Details
7/19/2010Q1 2011$0.38$0.32ViewN/AView Earnings Details
5/10/2010Q4 2010$0.27$0.27ViewN/AView Earnings Details
1/19/2010Q3 2010$0.23$0.25ViewN/AView Earnings Details
10/19/2009Q2 2010$0.28$0.28ViewN/AView Earnings Details
7/20/2009Q1 2010$0.31$0.36ViewN/AView Earnings Details
5/11/2009Q4 2009$0.22$0.25ViewN/AView Earnings Details
1/20/2009Q3 2009$0.20$0.21ViewN/AView Earnings Details
10/20/2008Q2 2009$0.20$0.25ViewN/AView Earnings Details
7/21/2008Q1 2009$0.27$0.28ViewN/AView Earnings Details
5/12/2008Q4 2008$0.18$0.20ViewN/AView Earnings Details
1/22/2008Q3 2008$0.14$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

1-800-PetMeds (NASDAQ:PETS) Dividend Information

1-800-PetMeds pays an annual dividend of $1.00 per share, with a dividend yield of 2.80%. PETS's most recent quarterly dividend payment was Friday, February 16. 1-800-PetMeds pays out 85.47% of its earnings out as a dividend.
Most Recent Dividend:2/16/2018
Annual Dividend:$1.00
Dividend Yield:2.80%
Payout Ratio:85.47% (Trailing 12 Months of Earnings)
56.50% (Based on This Year's Estimates)
46.51% (Based on Next Year's Estimates)
Dividend Payments by Quarter for 1-800-PetMeds (NASDAQ:PETS)

1-800-PetMeds (NASDAQ:PETS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/22/2018quarterly$0.252.4%2/2/20182/5/20182/16/2018
10/24/2017quarterly$0.202.08%11/3/201711/6/201711/17/2017
7/24/2017quarterly$0.201.66%8/3/20178/7/20178/18/2017
5/8/2017quarterly$0.205/17/20175/19/20175/26/2017
1/23/2017quarterly$0.193.61%2/2/20172/6/20172/17/2017
10/24/2016quarterly$0.193.84%11/3/201611/7/201611/18/2016
7/25/2016quarterly$0.193.71%8/4/20168/8/20168/19/2016
5/9/2016quarterly$0.193.9%5/18/20165/20/20165/27/2016
1/25/2016quarterly$0.184.04%2/4/20162/8/20162/19/2016
10/19/2015quarterly$0.184.28%10/29/201511/2/201511/13/2015
7/20/2015quarterly$0.184.23%7/30/20158/3/20158/14/2015
5/4/2015quarterly$0.184.41%5/13/20155/15/20155/22/2015
1/20/2015quarterly$0.174.2%1/30/20152/3/20152/13/2015
10/20/2014quarterly$0.1710/30/201411/3/201411/14/2014
7/21/2014quarterly$0.174.79%7/31/20148/4/20148/15/2014
5/5/2014quarterly$0.175.22%5/14/20145/16/20145/23/2014
1/30/2014quarterly$0.175.14%2/10/20142/12/20142/21/2014
10/28/2013quarterly$0.174.56%11/6/201311/8/201311/22/2013
7/26/2013quarterly$0.174.16%8/8/20138/12/20138/23/2013
5/3/2013quarterly$0.154.65%5/13/20135/15/20135/24/2013
1/28/2013quarterly$0.154.64%2/6/20132/8/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

1-800-PetMeds (NASDAQ PETS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 91.43%
Insider Trading History for 1-800-PetMeds (NASDAQ:PETS)
Insider Trading History for 1-800-PetMeds (NASDAQ:PETS)

1-800-PetMeds (NASDAQ PETS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Ronald J KornDirectorSell5,000$48.38$241,900.0068,833View SEC Filing  
1/22/2018Menderes AkdagCEOSell10,000$57.00$570,000.00470,000View SEC Filing  
1/11/2018Menderes AkdagCEOSell30,000$51.00$1,530,000.00490,000View SEC Filing  
12/15/2017Gian FulgoniDirectorSell20,000$44.38$887,600.0055,900View SEC Filing  
10/27/2017Ronald J KornDirectorSell1,000$35.57$35,570.0073,833View SEC Filing  
8/1/2017Robert C SchweitzerDirectorSell2,500$49.18$122,950.0088,834View SEC Filing  
7/28/2017Ronald J KornDirectorSell5,000$48.18$240,900.0067,333View SEC Filing  
7/27/2017Bruce S RosenbloomCFOSell6,833$50.18$342,879.9418,534View SEC Filing  
7/27/2017Robert C SchweitzerDirectorSell5,000$48.60$243,000.0083,834View SEC Filing  
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.0046,000View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.0068,400View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.0025,267View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.0034,267View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00520,000View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.0035,767View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25532,674View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50550,000View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.0051,000View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.0038,767View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00590,000View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.0041,767View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00600,000View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00610,000View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.0043,267View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.0090,334View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.0094,834View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.0075,333View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.0044,767View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.0046,267View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.0049,267View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.0071,833View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.0050,767View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.0076,833View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00618,000View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.0072,833View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.0073,833View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

1-800-PetMeds (NASDAQ PETS) News Headlines

Source:
DateHeadline
The Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed ExpressThe Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed Express
finance.yahoo.com - April 20 at 5:28 PM
Contrasting 1-800-PetMeds (PETS) & Express Scripts (ESRX)Contrasting 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 18 at 5:15 PM
1-800-PetMeds (PETS) Rating Lowered to Hold at BidaskClub1-800-PetMeds (PETS) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 18 at 9:51 AM
Is PetMed Express Inc (NASDAQ:PETS) A Smart Choice For Dividend Investors?Is PetMed Express Inc (NASDAQ:PETS) A Smart Choice For Dividend Investors?
finance.yahoo.com - April 17 at 8:20 AM
Financial Review: 1-800-PetMeds (PETS) & Express Scripts (ESRX)Financial Review: 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 14 at 5:11 PM
1-800-PetMeds (PETS) Rating Lowered to Hold at ValuEngine1-800-PetMeds (PETS) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - April 13 at 11:10 PM
Comparing 1-800-PetMeds (PETS) and Express Scripts (ESRX)Comparing 1-800-PetMeds (PETS) and Express Scripts (ESRX)
www.americanbankingnews.com - April 13 at 7:19 PM
1-800-PetMeds (PETS) Expected to Announce Quarterly Sales of $67.84 Million1-800-PetMeds (PETS) Expected to Announce Quarterly Sales of $67.84 Million
www.americanbankingnews.com - April 9 at 3:44 AM
Walgreens Boots Alliance (WBA) versus 1-800-PetMeds (PETS) Critical SurveyWalgreens Boots Alliance (WBA) versus 1-800-PetMeds (PETS) Critical Survey
www.americanbankingnews.com - April 8 at 11:23 AM
1-800-PetMeds (PETS) Downgraded by ValuEngine1-800-PetMeds (PETS) Downgraded by ValuEngine
www.americanbankingnews.com - April 8 at 11:17 AM
1-800-PetMeds (PETS) Expected to Announce Earnings of $0.44 Per Share1-800-PetMeds (PETS) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - April 7 at 8:08 AM
1-800-PetMeds (PETS) Receives Consensus Recommendation of "Hold" from Analysts1-800-PetMeds (PETS) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 6 at 1:36 AM
1-800-PetMeds (PETS) and Walgreens Boots Alliance (WBA) Critical Analysis1-800-PetMeds (PETS) and Walgreens Boots Alliance (WBA) Critical Analysis
www.americanbankingnews.com - April 4 at 9:21 PM
1-800-PetMeds (PETS) Lifted to Buy at ValuEngine1-800-PetMeds (PETS) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 10:33 AM
1-800-PetMeds (PETS) vs. Walgreens Boots Alliance (WBA) Financial Survey1-800-PetMeds (PETS) vs. Walgreens Boots Alliance (WBA) Financial Survey
www.americanbankingnews.com - April 2 at 7:16 PM
Should You Buy PetMed Express Inc (NASDAQ:PETS)?Should You Buy PetMed Express Inc (NASDAQ:PETS)?
finance.yahoo.com - March 30 at 5:38 PM
Amazon Teams Up With Monoprix, Bolsters Presence in EuropeAmazon Teams Up With Monoprix, Bolsters Presence in Europe
finance.yahoo.com - March 27 at 5:20 PM
Petmed Express (PETS) Rating Increased to Buy at ValuEnginePetmed Express (PETS) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - March 25 at 11:21 AM
$67.84 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter$67.84 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter
www.americanbankingnews.com - March 23 at 9:36 AM
Petmed Express Inc (PETS) Expected to Post Earnings of $0.44 Per SharePetmed Express Inc (PETS) Expected to Post Earnings of $0.44 Per Share
www.americanbankingnews.com - March 21 at 12:36 PM
Top Ranked Growth Stocks to Buy for March 19thTop Ranked Growth Stocks to Buy for March 19th
www.zacks.com - March 20 at 5:23 PM
A New Blackmark for United as Dog Dies in Overhead BinA New Blackmark for United as Dog Dies in Overhead Bin
www.wsj.com - March 14 at 8:20 AM
Does PetMed Express Inc’s (NASDAQ:PETS) Past Performance Indicate A Stronger Future?Does PetMed Express Inc’s (NASDAQ:PETS) Past Performance Indicate A Stronger Future?
finance.yahoo.com - March 13 at 7:24 PM
Petmed Express Inc (PETS) Given Average Recommendation of "Hold" by AnalystsPetmed Express Inc (PETS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 12 at 1:55 AM
Top 3 Stocks To Buy - Yahoo FinanceTop 3 Stocks To Buy - Yahoo Finance
finance.yahoo.com - March 8 at 6:55 PM
Petmed Express Inc to Post FY2018 Earnings of $1.77 Per Share, Northcoast Research Forecasts (PETS)Petmed Express Inc to Post FY2018 Earnings of $1.77 Per Share, Northcoast Research Forecasts (PETS)
www.americanbankingnews.com - March 8 at 9:08 AM
Top 3 Stocks To BuyTop 3 Stocks To Buy
finance.yahoo.com - March 8 at 8:14 AM
Petmed Express Inc (PETS) Stake Lowered by Schroder Investment Management GroupPetmed Express Inc (PETS) Stake Lowered by Schroder Investment Management Group
www.americanbankingnews.com - March 6 at 10:52 AM
Zacks: Brokerages Expect Petmed Express Inc (PETS) Will Announce Quarterly Sales of $67.64 MillionZacks: Brokerages Expect Petmed Express Inc (PETS) Will Announce Quarterly Sales of $67.64 Million
www.americanbankingnews.com - March 6 at 10:28 AM
WINTON GROUP Ltd Has $7.47 Million Position in Petmed Express Inc (PETS)WINTON GROUP Ltd Has $7.47 Million Position in Petmed Express Inc (PETS)
www.americanbankingnews.com - March 4 at 2:29 PM
95,653 Shares in Petmed Express Inc (PETS) Acquired by Maverick Capital Ltd.95,653 Shares in Petmed Express Inc (PETS) Acquired by Maverick Capital Ltd.
www.americanbankingnews.com - March 4 at 1:40 PM
 Brokerages Expect Petmed Express Inc (PETS) to Post $0.43 EPS Brokerages Expect Petmed Express Inc (PETS) to Post $0.43 EPS
www.americanbankingnews.com - March 4 at 5:10 AM
Landscape Capital Management L.L.C. Buys Shares of 164,420 Petmed Express Inc (PETS)Landscape Capital Management L.L.C. Buys Shares of 164,420 Petmed Express Inc (PETS)
www.americanbankingnews.com - March 2 at 5:26 PM
PetMed (PET) Focuses on Advertising to Boost New Order Sales - NasdaqPetMed (PET) Focuses on Advertising to Boost New Order Sales - Nasdaq
www.nasdaq.com - February 28 at 8:09 AM
Integra LifeSciences (IART) Beats on Q4 Earnings & RevenuesIntegra LifeSciences (IART) Beats on Q4 Earnings & Revenues
finance.yahoo.com - February 28 at 8:09 AM
Smith Asset Management Group LP Acquires 13,189 Shares of Petmed Express Inc (PETS)Smith Asset Management Group LP Acquires 13,189 Shares of Petmed Express Inc (PETS)
www.americanbankingnews.com - February 25 at 2:28 PM
Petmed Express (PETS) Rating Lowered to Hold at ValuEnginePetmed Express (PETS) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - February 25 at 12:34 AM
After Wayfairs Earnings Miss, Buy These E-Commerce Stocks InsteadAfter Wayfair's Earnings Miss, Buy These E-Commerce Stocks Instead
finance.yahoo.com - February 22 at 5:42 PM
Why Is PetMed Express (PETS) Down 9.8% Since the Last Earnings Report? - NasdaqWhy Is PetMed Express (PETS) Down 9.8% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - February 22 at 8:13 AM
Petmed Express Inc (PETS) Expected to Post Quarterly Sales of $67.64 MillionPetmed Express Inc (PETS) Expected to Post Quarterly Sales of $67.64 Million
www.americanbankingnews.com - February 17 at 10:26 AM
 Brokerages Expect Petmed Express Inc (PETS) to Announce $0.43 EPS Brokerages Expect Petmed Express Inc (PETS) to Announce $0.43 EPS
www.americanbankingnews.com - February 15 at 11:10 AM
Petmed Express Inc (PETS) Given Average Rating of "Hold" by BrokeragesPetmed Express Inc (PETS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 15 at 1:46 AM
DaVita (DVA) Beats Q4 Earnings Estimates, Misses RevenuesDaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues
finance.yahoo.com - February 14 at 8:58 AM
GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue EstimatesGNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates
finance.yahoo.com - February 14 at 8:58 AM
Cardiovascular Systems (CSII) Q2 Earnings Top, Revenues LagCardiovascular Systems (CSII) Q2 Earnings Top, Revenues Lag
finance.yahoo.com - February 8 at 3:38 PM
Bull Of The Day PetMed Express (PETS)Bull Of The Day PetMed Express (PETS)
finance.yahoo.com - February 7 at 8:40 AM
Top Stock Picks for the Week of February 5thTop Stock Picks for the Week of February 5th
finance.yahoo.com - February 6 at 3:37 PM
Should You Be Tempted To Buy PetMed Express Inc (NASDAQ:PETS) At Its Current PE Ratio?Should You Be Tempted To Buy PetMed Express Inc (NASDAQ:PETS) At Its Current PE Ratio?
finance.yahoo.com - February 5 at 3:36 PM
Investing Lessons From My Hate Mail - Investorplace.comInvesting Lessons From My Hate Mail - Investorplace.com
www.investorplace.com - February 3 at 8:40 AM
PetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for February 02, 2018 - NasdaqPetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for February 02, 2018 - Nasdaq
www.nasdaq.com - February 3 at 8:40 AM

SEC Filings

1-800-PetMeds (NASDAQ:PETS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

1-800-PetMeds (NASDAQ:PETS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

1-800-PetMeds (NASDAQ PETS) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.